Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Extracellular matrix proteins as diagnostic markers of breast carcinoma

9 Mar 2018

Abstract excerpt

Changes in amount and composition of extracellular matrix (ECM) are considered a hallmark of tumor development. We tested the hypothesis that abnormal production of ECM components leads to blood-released ECM molecules representing tumor circulating biomarkers. Candidate genes were selected through class comparison in two publicly available datasets and confirmed in paired normal and tumor associated fibroblasts...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Bone and Dental Protein Studies
Share to Protease and Inhibitor Mechanisms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29521413
DOI: 10.1002/jcp.26513

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Extracellular matrix proteins as diagnostic markers of breast carcinomaPMID 29521413Read ↗

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcomeSemantic proximity Read ↗

Transcriptome-wide analysis reveals potential roles of CFD and ANGPTL4 in fibroblasts regulating B cell lineage for extracellular matrix-driven clustering and novel avenues for immunotherapy in breast cancerSemantic proximity Read ↗

High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkersSemantic proximity Read ↗

Quantitative Proteomics of Breast Benign and Malignant Tumors Reveals a Malignancy SignatureSemantic proximity Read ↗

Collagen and fibronectin promote an aggressive cancer phenotype in breast cancer cells but drive autonomous gene expression patterns.Semantic proximity Read ↗

Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screeningSemantic proximity Read ↗

Clinical value and potential mechanisms of COL8A1 upregulation in breast cancer: a comprehensive analysisSemantic proximity Read ↗

The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular MatricesSemantic proximity Read ↗

A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 YearsSemantic proximity Read ↗

ECM Remodeling in Breast Cancer with Different Grade: Contribution of 2D‐DIGE ProteomicsSemantic proximity Read ↗

Aberrant expression of collagen type X in solid tumor stroma is associated with EMT, immunosuppressive and pro-metastatic pathways, bone marrow stromal cell signatures, and poor survival prognosisSemantic proximity Read ↗

Collagen 1A1 (COL1A1) and Collagen11A1(COL11A1) as diagnostic biomarkers in Breast, colorectal and gastric cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.